Formulations of AG10
US11260047B2 · kind B2 · utility
2Cited by
59References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 2019 |
| Grant date | Mar 1, 2022 |
| Priority date | — |
| Expiry date | Aug 16, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2833
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides high-load tablet formulations of AG10 or a pharmaceutically acceptable salt thereof. In some aspects, provided herein are table formulations of AG10 or a pharmaceutically acceptable salt thereof that include at least 40% or more AG10 by weight and at least one pharmaceutical excipient selected from one or more fillers, one or more binders, one or more disintegrants, and one or more lubricants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.